These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
20 related articles for article (PubMed ID: 11548451)
1. [Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane]. Nezhinskaia GI; Val'dman EA; Nazarov PG; Sapronov NS Eksp Klin Farmakol; 2003; 66(3):44-6. PubMed ID: 12924233 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats]. Kovalev GI; Rodionov AP; Petrenko ES; Zolotarev IuA Eksp Klin Farmakol; 2003; 66(3):50-2. PubMed ID: 12924235 [TBL] [Abstract][Full Text] [Related]
3. [Estimation of the protective effect of the novel potential antiparkinsonian agent himantane against MPTP neurotoxicity]. Val'dman EA; Nerobkova LN; Voronina TA Eksp Klin Farmakol; 2004; 67(1):7-10. PubMed ID: 15079899 [TBL] [Abstract][Full Text] [Related]
4. [Effect of a new antiparkinsonian drug himantane on monoamine oxidase activity]. Val'dman EA; Voronina TA; Aksenova LN; Buneeva OA; Medvedev AE Eksp Klin Farmakol; 2003; 66(5):3-5. PubMed ID: 14650204 [TBL] [Abstract][Full Text] [Related]
5. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice]. Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515 [TBL] [Abstract][Full Text] [Related]
6. [On the question of a uniform action principle of immunologic adjuvants]. Finger H Arch Hyg Bakteriol; 1965 Dec; 149(7):732-46. PubMed ID: 5333436 [No Abstract] [Full Text] [Related]
7. [Immunotropic activity of a potential antiparkinson agent himantane]. Nezhinskaia GI; Val'dman EA; Nazarov PG; Voronina TA Eksp Klin Farmakol; 2001; 64(2):60-3. PubMed ID: 11548451 [TBL] [Abstract][Full Text] [Related]